Company news
Viromed Medical Ag (XETR:VME) news
Viromed Medical Ag news releases on 6ix. Latest, Sep 28, 2026: Viromed Medical AG advances product development and market launch in the first half of 2026…
Press releases & updates
Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance
September 28, 2026
Prof. Dr. Michael A. Rübhausen Joins the Medical Advisory Board of Viromed Medical AG
September 2, 2026
Viromed Medical AG receives ÜTS registration for ViroCAP® in Turkey and can fulfill existing orders
August 28, 2026
Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
August 10, 2026
Viromed Medical AG: Update on the Planned Acquisition of relyon plasma GmbH
July 27, 2026
Viromed Medical AG: Study on Cold Plasma Application in the Lung Successfully Completed
June 2, 2026
Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income
May 22, 2026
Viromed Medical AG signs exclusive distribution partnership with NEBU-TEC for PulmoPlas® with a focus on veterinary applications
May 18, 2026
Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026
May 11, 2026
Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
May 8, 2026
Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH
April 21, 2026
Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
March 23, 2026
Viromed Medical AG: Anna Heinen appointed to the Supervisory Board
March 19, 2026
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology
March 4, 2026
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH
March 3, 2026
Viromed Medical AG: Globally unique preclinical data base – Saarland validation as key step toward first physical lung application
February 16, 2026